If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobile Tornado Regulatory News (MBT)

  • There is currently no data for MBT

Options to Directors

10 Feb 2012 08:54

RNS Number : 1906X
Mobile Tornado Group PLC
10 February 2012
 



Mobile Tornado Group plc

 

("Mobile Tornado" or the "Company")

 

Directors' Options

 

 

The Board of Mobile Tornado (AIM: MBT) has awarded options to Directors as follows:

 

Director

No of options

Exercise Price

Jeremy Fenn

3,000,000

7.5pence

Jorge Pinievsky

3,000,000

7.5pence

 

The options may not be exercised prior to 3 January 2015 (save as may be provided under the Rules of the Scheme) or after 3 January 2022.

 

Following this award Jeremy Fenn has 7,670,396 Ordinary Shares of 2p in Mobile Tornado representing 4.1% of the issued share capital, and 3,000,000 options.

 

Jorge Pinievsky has 9,168,624 Ordinary Shares of 2p in Mobile Tornado representing 5.0% of the issued share capital, and 3,000,000 options.

 

 

For further details please contact:

 

Mobile Tornado Group plc

Jeremy Fenn, Chief Executive

 

+44 (0) 7734 475888

Northland Capital Partners Limited

+44 (0)20 7996 8800

Shane Gallwey / Gavin Burnell

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSTMMPTMBABMTT
Date   Source Headline
9th Sep 20257:00 amRNSCancellation - Mobile Tornado Group PLC
2nd Sep 20256:00 pmRNSMobile Tornado Group
1st Sep 20252:45 pmRNSResult of General Meeting
19th Aug 20253:04 pmRNSResult of AGM
11th Aug 20257:00 amRNSProposed Cancellation and Notice of GM
23rd Jul 20257:00 amRNSNotice of AGM and amendment to preference shares
12th Jun 20257:00 amRNSBoard Changes
12th Jun 20257:00 amRNS2024 Final Results
8th Jan 20253:45 pmRNSGrant of security
7th Jan 20253:16 pmRNSChange of Registered Office
29th Nov 20245:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSSubscription to raise £425,000 and trading update
10th Oct 20244:05 pmRNSDirector dealing
27th Sep 20244:17 pmRNSLicence to occupy agreement
26th Sep 20247:00 amRNSHalf-year Report
6th Sep 20243:28 pmRNSDirectorate Change
30th Aug 20243:03 pmRNSAssignment & variation of revolving loan facility
12th Aug 20242:33 pmRNSResult of AGM
15th Jul 202412:37 pmRNSNotice of AGM and amendment to preference shares
20th Jun 20247:00 amRNSBoard Changes
20th Jun 20247:00 amRNSFinal Results
8th May 20247:00 amRNSContract win with MNO in Middle East
24th Jan 20247:00 amRNSFull year trading update
13th Nov 20237:00 amRNSDirector dealing & update re debts to InTechnology
28th Sep 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSVariation to loan facility and notice of results
27th Jun 202312:39 pmRNSResult of AGM
2nd Jun 20237:00 amRNSNotice of AGM and amendment to preference shares
27th Apr 20237:00 amRNS2022 Final Results
25th Apr 20237:00 amRNSPTT contract win
31st Mar 20235:00 pmRNSTotal Voting Rights
14th Mar 202311:27 amRNSHolding(s) in Company
1st Mar 20237:00 amRNSSubscription, Debt Conversion and Trading Update
9th Jan 20237:00 amRNSBoard changes
28th Sep 20227:00 amRNSHalf-year Report
29th Jun 202212:52 pmRNSResult of AGM
31st May 202212:33 pmRNSNotice of AGM and amendment to preference shares
4th Apr 20224:41 pmRNSSecond Price Monitoring Extn
4th Apr 20224:35 pmRNSPrice Monitoring Extension
1st Apr 20222:06 pmRNSSecond Price Monitoring Extn
1st Apr 20222:00 pmRNSPrice Monitoring Extension
31st Mar 20227:00 amRNS2021 Final Results
30th Mar 20229:00 amRNSPrice Monitoring Extension
24th Mar 20227:00 amRNSVariation to loan facility and notice of results
1st Feb 20227:00 amRNSFull Year Trading Update
1st Dec 20217:00 amRNSUpdate re. Canadian customer
29th Sep 20217:00 amRNS2021 Interim Results
24th Sep 20217:00 amRNSExtension to facility & notice of interim results
29th Jun 202112:00 pmRNSResult of AGM
4th Jun 20211:00 pmRNSNotice of AGM and amendment to preference shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.